Trident Lifeline Limited (BOM:543616)

India · Delayed Price · Currency is INR

260.20

-3.75 (-1.42%)

At close: Jul 7, 2026

-3.63% (1Y)

Market Cap	3.10B +5.9%
Revenue (ttm)	1.29B +48.4%
Net Income	190.41M +62.1%
EPS	16.32 +59.7%
Shares Out	11.93M
PE Ratio	15.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,000
Open	259.65
Previous Close	263.95
Day's Range	259.60 - 262.90
52-Week Range	229.95 - 328.00
Beta	-0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 16, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target... [Read more]

Industry Pharmaceutical Preparations

Founded 2014

Employees 74

Stock Exchange Bombay Stock Exchange

Ticker Symbol 543616

Full Company Profile

Financial Performance

In fiscal year 2026, Trident Lifeline's revenue was 1.29 billion, an increase of 48.36% compared to the previous year's 869.65 million. Earnings were 190.41 million, an increase of 62.08%.

Financial Statements